HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 29-AUG-03 1QVV TITLE CRYSTAL STRUCTURE OF THE S. CEREVISIAE YDR533C PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: YDR533C PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: YDR533C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET9 KEYWDS ALPHA/BETA HYDROLASE FOLD, CATALYTIC TRIAD, HEAT SHOCK PROTEIN, KEYWDS 2 STRUCTURAL GENOMICS, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR M.GRAILLE,N.LEULLIOT,S.QUEVILLON-CHERUEL,H.VAN TILBEURGH REVDAT 4 15-JUL-20 1QVV 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1QVV 1 VERSN REVDAT 2 13-JUL-04 1QVV 1 JRNL REVDAT 1 30-MAR-04 1QVV 0 JRNL AUTH M.GRAILLE,S.QUEVILLON-CHERUEL,N.LEULLIOT,C.Z.ZHOU, JRNL AUTH 2 I.L.DE LA SIERRA GALLAY,L.JACQUAMET,J.L.FERRER,D.LIGER, JRNL AUTH 3 A.POUPON,J.JANIN,H.VAN TILBEURGH JRNL TITL CRYSTAL STRUCTURE OF THE YDR533C S. CEREVISIAE PROTEIN, A JRNL TITL 2 CLASS II MEMBER OF THE HSP31 FAMILY JRNL REF STRUCTURE V. 12 839 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 15130476 JRNL DOI 10.1016/J.STR.2004.02.030 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 379163.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 77.3 REMARK 3 NUMBER OF REFLECTIONS : 31354 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1557 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3920 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 228 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7227 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 325 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.23000 REMARK 3 B22 (A**2) : 4.71000 REMARK 3 B33 (A**2) : -8.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 36.13 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QVV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020131. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.004 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41388 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49800 REMARK 200 FOR SHELL : 1.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG 4000, 50MM NA/K PHOSPHATE REMARK 280 BUFFER, PH 6.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.50950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.86900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.81800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.86900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.50950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.81800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 33.50950 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 46.81800 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 151.73800 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 33.50950 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 140.45400 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 151.73800 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 PRO D 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY C 107 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 GLY D 107 N - CA - C ANGL. DEV. = -16.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 16 124.32 -39.32 REMARK 500 PHE A 17 -55.20 -128.75 REMARK 500 ALA A 106 -142.99 -128.46 REMARK 500 CME A 138 -118.52 58.13 REMARK 500 PRO A 141 -8.26 -58.53 REMARK 500 ALA B 2 117.63 156.00 REMARK 500 ASN B 14 64.82 -155.24 REMARK 500 PHE B 17 -66.33 -120.05 REMARK 500 ILE B 88 137.07 -38.38 REMARK 500 ALA B 106 -139.64 -135.35 REMARK 500 HIS B 108 -14.22 -45.88 REMARK 500 ALA B 117 69.01 -69.24 REMARK 500 CME B 138 -123.47 53.59 REMARK 500 ASP B 145 86.69 -59.57 REMARK 500 LEU B 147 103.27 -57.58 REMARK 500 ASN C 14 60.26 -154.97 REMARK 500 PHE C 17 -46.81 -131.57 REMARK 500 VAL C 28 -72.66 -24.06 REMARK 500 ALA C 106 -143.69 -126.22 REMARK 500 CME C 138 -108.08 67.84 REMARK 500 ASP C 145 98.07 -66.32 REMARK 500 ASN D 14 41.82 -145.42 REMARK 500 PHE D 17 -74.76 -125.48 REMARK 500 SER D 19 48.25 -74.77 REMARK 500 ASP D 20 7.10 -153.62 REMARK 500 ALA D 106 -140.25 -123.51 REMARK 500 CME D 138 -119.58 61.12 REMARK 500 PRO D 141 -8.94 -56.73 REMARK 500 LEU D 235 -19.11 -43.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QVW RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH FOUR RESIDUES MUTATED TO METHIONINE FOR MAD REMARK 900 PHASING BUT NOT SELENOMET LABELLED REMARK 900 RELATED ID: 1QVZ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH FOUR RESIDUES MUTATED TO SELENOMETHIONE DBREF 1QVV A 1 237 UNP Q04432 HSP31_YEAST 1 237 DBREF 1QVV B 1 237 UNP Q04432 HSP31_YEAST 1 237 DBREF 1QVV C 1 237 UNP Q04432 HSP31_YEAST 1 237 DBREF 1QVV D 1 237 UNP Q04432 HSP31_YEAST 1 237 SEQADV 1QVV CME A 138 UNP Q04432 CYS 138 MODIFIED RESIDUE SEQADV 1QVV CME B 138 UNP Q04432 CYS 138 MODIFIED RESIDUE SEQADV 1QVV CME C 138 UNP Q04432 CYS 138 MODIFIED RESIDUE SEQADV 1QVV CME D 138 UNP Q04432 CYS 138 MODIFIED RESIDUE SEQRES 1 A 237 MET ALA PRO LYS LYS VAL LEU LEU ALA LEU THR SER TYR SEQRES 2 A 237 ASN ASP VAL PHE TYR SER ASP GLY ALA LYS THR GLY VAL SEQRES 3 A 237 PHE VAL VAL GLU ALA LEU HIS PRO PHE ASN THR PHE ARG SEQRES 4 A 237 LYS GLU GLY PHE GLU VAL ASP PHE VAL SER GLU THR GLY SEQRES 5 A 237 LYS PHE GLY TRP ASP GLU HIS SER LEU ALA LYS ASP PHE SEQRES 6 A 237 LEU ASN GLY GLN ASP GLU THR ASP PHE LYS ASN LYS ASP SEQRES 7 A 237 SER ASP PHE ASN LYS THR LEU ALA LYS ILE LYS THR PRO SEQRES 8 A 237 LYS GLU VAL ASN ALA ASP ASP TYR GLN ILE PHE PHE ALA SEQRES 9 A 237 SER ALA GLY HIS GLY THR LEU PHE ASP TYR PRO LYS ALA SEQRES 10 A 237 LYS ASP LEU GLN ASP ILE ALA SER GLU ILE TYR ALA ASN SEQRES 11 A 237 GLY GLY VAL VAL ALA ALA VAL CME HIS GLY PRO ALA ILE SEQRES 12 A 237 PHE ASP GLY LEU THR ASP LYS LYS THR GLY ARG PRO LEU SEQRES 13 A 237 ILE GLU GLY LYS SER ILE THR GLY PHE THR ASP VAL GLY SEQRES 14 A 237 GLU THR ILE LEU GLY VAL ASP SER ILE LEU LYS ALA LYS SEQRES 15 A 237 ASN LEU ALA THR VAL GLU ASP VAL ALA LYS LYS TYR GLY SEQRES 16 A 237 ALA LYS TYR LEU ALA PRO VAL GLY PRO TRP ASP ASP TYR SEQRES 17 A 237 SER ILE THR ASP GLY ARG LEU VAL THR GLY VAL ASN PRO SEQRES 18 A 237 ALA SER ALA HIS SER THR ALA VAL ARG SER ILE ASP ALA SEQRES 19 A 237 LEU LYS ASN SEQRES 1 B 237 MET ALA PRO LYS LYS VAL LEU LEU ALA LEU THR SER TYR SEQRES 2 B 237 ASN ASP VAL PHE TYR SER ASP GLY ALA LYS THR GLY VAL SEQRES 3 B 237 PHE VAL VAL GLU ALA LEU HIS PRO PHE ASN THR PHE ARG SEQRES 4 B 237 LYS GLU GLY PHE GLU VAL ASP PHE VAL SER GLU THR GLY SEQRES 5 B 237 LYS PHE GLY TRP ASP GLU HIS SER LEU ALA LYS ASP PHE SEQRES 6 B 237 LEU ASN GLY GLN ASP GLU THR ASP PHE LYS ASN LYS ASP SEQRES 7 B 237 SER ASP PHE ASN LYS THR LEU ALA LYS ILE LYS THR PRO SEQRES 8 B 237 LYS GLU VAL ASN ALA ASP ASP TYR GLN ILE PHE PHE ALA SEQRES 9 B 237 SER ALA GLY HIS GLY THR LEU PHE ASP TYR PRO LYS ALA SEQRES 10 B 237 LYS ASP LEU GLN ASP ILE ALA SER GLU ILE TYR ALA ASN SEQRES 11 B 237 GLY GLY VAL VAL ALA ALA VAL CME HIS GLY PRO ALA ILE SEQRES 12 B 237 PHE ASP GLY LEU THR ASP LYS LYS THR GLY ARG PRO LEU SEQRES 13 B 237 ILE GLU GLY LYS SER ILE THR GLY PHE THR ASP VAL GLY SEQRES 14 B 237 GLU THR ILE LEU GLY VAL ASP SER ILE LEU LYS ALA LYS SEQRES 15 B 237 ASN LEU ALA THR VAL GLU ASP VAL ALA LYS LYS TYR GLY SEQRES 16 B 237 ALA LYS TYR LEU ALA PRO VAL GLY PRO TRP ASP ASP TYR SEQRES 17 B 237 SER ILE THR ASP GLY ARG LEU VAL THR GLY VAL ASN PRO SEQRES 18 B 237 ALA SER ALA HIS SER THR ALA VAL ARG SER ILE ASP ALA SEQRES 19 B 237 LEU LYS ASN SEQRES 1 C 237 MET ALA PRO LYS LYS VAL LEU LEU ALA LEU THR SER TYR SEQRES 2 C 237 ASN ASP VAL PHE TYR SER ASP GLY ALA LYS THR GLY VAL SEQRES 3 C 237 PHE VAL VAL GLU ALA LEU HIS PRO PHE ASN THR PHE ARG SEQRES 4 C 237 LYS GLU GLY PHE GLU VAL ASP PHE VAL SER GLU THR GLY SEQRES 5 C 237 LYS PHE GLY TRP ASP GLU HIS SER LEU ALA LYS ASP PHE SEQRES 6 C 237 LEU ASN GLY GLN ASP GLU THR ASP PHE LYS ASN LYS ASP SEQRES 7 C 237 SER ASP PHE ASN LYS THR LEU ALA LYS ILE LYS THR PRO SEQRES 8 C 237 LYS GLU VAL ASN ALA ASP ASP TYR GLN ILE PHE PHE ALA SEQRES 9 C 237 SER ALA GLY HIS GLY THR LEU PHE ASP TYR PRO LYS ALA SEQRES 10 C 237 LYS ASP LEU GLN ASP ILE ALA SER GLU ILE TYR ALA ASN SEQRES 11 C 237 GLY GLY VAL VAL ALA ALA VAL CME HIS GLY PRO ALA ILE SEQRES 12 C 237 PHE ASP GLY LEU THR ASP LYS LYS THR GLY ARG PRO LEU SEQRES 13 C 237 ILE GLU GLY LYS SER ILE THR GLY PHE THR ASP VAL GLY SEQRES 14 C 237 GLU THR ILE LEU GLY VAL ASP SER ILE LEU LYS ALA LYS SEQRES 15 C 237 ASN LEU ALA THR VAL GLU ASP VAL ALA LYS LYS TYR GLY SEQRES 16 C 237 ALA LYS TYR LEU ALA PRO VAL GLY PRO TRP ASP ASP TYR SEQRES 17 C 237 SER ILE THR ASP GLY ARG LEU VAL THR GLY VAL ASN PRO SEQRES 18 C 237 ALA SER ALA HIS SER THR ALA VAL ARG SER ILE ASP ALA SEQRES 19 C 237 LEU LYS ASN SEQRES 1 D 237 MET ALA PRO LYS LYS VAL LEU LEU ALA LEU THR SER TYR SEQRES 2 D 237 ASN ASP VAL PHE TYR SER ASP GLY ALA LYS THR GLY VAL SEQRES 3 D 237 PHE VAL VAL GLU ALA LEU HIS PRO PHE ASN THR PHE ARG SEQRES 4 D 237 LYS GLU GLY PHE GLU VAL ASP PHE VAL SER GLU THR GLY SEQRES 5 D 237 LYS PHE GLY TRP ASP GLU HIS SER LEU ALA LYS ASP PHE SEQRES 6 D 237 LEU ASN GLY GLN ASP GLU THR ASP PHE LYS ASN LYS ASP SEQRES 7 D 237 SER ASP PHE ASN LYS THR LEU ALA LYS ILE LYS THR PRO SEQRES 8 D 237 LYS GLU VAL ASN ALA ASP ASP TYR GLN ILE PHE PHE ALA SEQRES 9 D 237 SER ALA GLY HIS GLY THR LEU PHE ASP TYR PRO LYS ALA SEQRES 10 D 237 LYS ASP LEU GLN ASP ILE ALA SER GLU ILE TYR ALA ASN SEQRES 11 D 237 GLY GLY VAL VAL ALA ALA VAL CME HIS GLY PRO ALA ILE SEQRES 12 D 237 PHE ASP GLY LEU THR ASP LYS LYS THR GLY ARG PRO LEU SEQRES 13 D 237 ILE GLU GLY LYS SER ILE THR GLY PHE THR ASP VAL GLY SEQRES 14 D 237 GLU THR ILE LEU GLY VAL ASP SER ILE LEU LYS ALA LYS SEQRES 15 D 237 ASN LEU ALA THR VAL GLU ASP VAL ALA LYS LYS TYR GLY SEQRES 16 D 237 ALA LYS TYR LEU ALA PRO VAL GLY PRO TRP ASP ASP TYR SEQRES 17 D 237 SER ILE THR ASP GLY ARG LEU VAL THR GLY VAL ASN PRO SEQRES 18 D 237 ALA SER ALA HIS SER THR ALA VAL ARG SER ILE ASP ALA SEQRES 19 D 237 LEU LYS ASN MODRES 1QVV CME A 138 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1QVV CME B 138 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1QVV CME C 138 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1QVV CME D 138 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 138 10 HET CME B 138 10 HET CME C 138 10 HET CME D 138 10 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 5 HOH *325(H2 O) HELIX 1 1 PHE A 27 GLY A 42 1 16 HELIX 2 2 ASP A 57 ALA A 62 5 6 HELIX 3 3 GLY A 68 ASN A 76 1 9 HELIX 4 4 SER A 79 ALA A 86 1 8 HELIX 5 5 THR A 90 VAL A 94 5 5 HELIX 6 6 ASN A 95 TYR A 99 5 5 HELIX 7 7 GLY A 109 TYR A 114 1 6 HELIX 8 8 ALA A 117 ASN A 130 1 14 HELIX 9 9 HIS A 139 ASP A 145 5 7 HELIX 10 10 THR A 166 LEU A 173 1 8 HELIX 11 11 VAL A 175 LYS A 182 1 8 HELIX 12 12 THR A 186 TYR A 194 1 9 HELIX 13 13 ASN A 220 ALA A 222 5 3 HELIX 14 14 SER A 223 ALA A 234 1 12 HELIX 15 15 LEU A 235 ASN A 237 5 3 HELIX 16 16 PHE B 27 GLU B 41 1 15 HELIX 17 17 ASP B 57 ALA B 62 5 6 HELIX 18 18 ASN B 67 ASN B 76 1 10 HELIX 19 19 SER B 79 LYS B 87 1 9 HELIX 20 20 THR B 90 VAL B 94 5 5 HELIX 21 21 ASN B 95 TYR B 99 5 5 HELIX 22 22 GLY B 109 TYR B 114 1 6 HELIX 23 23 ALA B 117 ASN B 130 1 14 HELIX 24 24 HIS B 139 ASP B 145 5 7 HELIX 25 25 THR B 166 LEU B 173 1 8 HELIX 26 26 VAL B 175 LYS B 182 1 8 HELIX 27 27 THR B 186 TYR B 194 1 9 HELIX 28 28 ASN B 220 ALA B 222 5 3 HELIX 29 29 SER B 223 ALA B 234 1 12 HELIX 30 30 LEU B 235 ASN B 237 5 3 HELIX 31 31 PHE C 27 GLU C 41 1 15 HELIX 32 32 ASP C 57 ALA C 62 5 6 HELIX 33 33 ASN C 67 ASN C 76 1 10 HELIX 34 34 SER C 79 ALA C 86 1 8 HELIX 35 35 THR C 90 VAL C 94 5 5 HELIX 36 36 ASN C 95 TYR C 99 5 5 HELIX 37 37 GLY C 109 TYR C 114 1 6 HELIX 38 38 ALA C 117 ASN C 130 1 14 HELIX 39 39 HIS C 139 ASP C 145 5 7 HELIX 40 40 THR C 166 LEU C 173 1 8 HELIX 41 41 VAL C 175 ASN C 183 1 9 HELIX 42 42 THR C 186 TYR C 194 1 9 HELIX 43 43 ASN C 220 ALA C 222 5 3 HELIX 44 44 SER C 223 ALA C 234 1 12 HELIX 45 45 LEU C 235 ASN C 237 5 3 HELIX 46 46 PHE D 27 GLU D 41 1 15 HELIX 47 47 ASP D 57 ALA D 62 5 6 HELIX 48 48 ASN D 67 ASN D 76 1 10 HELIX 49 49 SER D 79 ALA D 86 1 8 HELIX 50 50 THR D 90 VAL D 94 5 5 HELIX 51 51 ASN D 95 TYR D 99 5 5 HELIX 52 52 GLY D 109 TYR D 114 1 6 HELIX 53 53 ALA D 117 ASN D 130 1 14 HELIX 54 54 HIS D 139 ASP D 145 5 7 HELIX 55 55 THR D 166 LEU D 173 1 8 HELIX 56 56 VAL D 175 LYS D 182 1 8 HELIX 57 57 THR D 186 TYR D 194 1 9 HELIX 58 58 ASN D 220 ALA D 222 5 3 HELIX 59 59 SER D 223 LEU D 235 1 13 SHEET 1 A 6 GLU A 44 SER A 49 0 SHEET 2 A 6 LYS A 5 LEU A 10 1 N VAL A 6 O ASP A 46 SHEET 3 A 6 ILE A 101 ALA A 104 1 O PHE A 103 N ALA A 9 SHEET 4 A 6 VAL A 133 ALA A 136 1 O ALA A 135 N PHE A 102 SHEET 5 A 6 LEU A 215 GLY A 218 1 O VAL A 216 N VAL A 134 SHEET 6 A 6 SER A 209 ASP A 212 -1 N ILE A 210 O THR A 217 SHEET 1 B 2 SER A 161 ILE A 162 0 SHEET 2 B 2 LYS A 197 TYR A 198 1 O LYS A 197 N ILE A 162 SHEET 1 C 6 GLU B 44 SER B 49 0 SHEET 2 C 6 LYS B 5 LEU B 10 1 N LEU B 8 O ASP B 46 SHEET 3 C 6 ILE B 101 ALA B 104 1 O PHE B 103 N ALA B 9 SHEET 4 C 6 VAL B 133 ALA B 136 1 O ALA B 135 N PHE B 102 SHEET 5 C 6 LEU B 215 GLY B 218 1 O VAL B 216 N VAL B 134 SHEET 6 C 6 SER B 209 ASP B 212 -1 N ASP B 212 O LEU B 215 SHEET 1 D 2 SER B 161 ILE B 162 0 SHEET 2 D 2 LYS B 197 TYR B 198 1 O LYS B 197 N ILE B 162 SHEET 1 E 6 GLU C 44 VAL C 48 0 SHEET 2 E 6 LYS C 5 ALA C 9 1 N LEU C 8 O ASP C 46 SHEET 3 E 6 ILE C 101 ALA C 104 1 O PHE C 103 N LEU C 7 SHEET 4 E 6 VAL C 133 VAL C 137 1 O ALA C 135 N PHE C 102 SHEET 5 E 6 LEU C 215 GLY C 218 1 O VAL C 216 N VAL C 134 SHEET 6 E 6 SER C 209 ASP C 212 -1 N ILE C 210 O THR C 217 SHEET 1 F 2 SER C 161 ILE C 162 0 SHEET 2 F 2 LYS C 197 TYR C 198 1 O LYS C 197 N ILE C 162 SHEET 1 G 6 GLU D 44 VAL D 48 0 SHEET 2 G 6 LYS D 5 ALA D 9 1 N LEU D 8 O ASP D 46 SHEET 3 G 6 ILE D 101 ALA D 104 1 O PHE D 103 N LEU D 7 SHEET 4 G 6 VAL D 133 VAL D 137 1 O ALA D 135 N PHE D 102 SHEET 5 G 6 LEU D 215 GLY D 218 1 O VAL D 216 N VAL D 134 SHEET 6 G 6 SER D 209 ASP D 212 -1 N ILE D 210 O THR D 217 SHEET 1 H 2 SER D 161 ILE D 162 0 SHEET 2 H 2 LYS D 197 TYR D 198 1 O LYS D 197 N ILE D 162 LINK C VAL A 137 N CME A 138 1555 1555 1.34 LINK C CME A 138 N HIS A 139 1555 1555 1.33 LINK C VAL B 137 N CME B 138 1555 1555 1.33 LINK C CME B 138 N HIS B 139 1555 1555 1.33 LINK C VAL C 137 N CME C 138 1555 1555 1.34 LINK C CME C 138 N HIS C 139 1555 1555 1.33 LINK C VAL D 137 N CME D 138 1555 1555 1.34 LINK C CME D 138 N HIS D 139 1555 1555 1.33 CRYST1 67.019 93.636 151.738 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014921 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010680 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006590 0.00000 MASTER 317 0 4 59 32 0 0 6 0 0 0 76 END